The Aurora Funds logo

The Aurora Funds

North America, North Carolina, United States, Durham

Description

The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information

Investor Profile

The Aurora Funds has made 71 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (30%)
  • Series A (27%)
  • Series C (15%)
  • Series Unknown (11%)
  • Series D (8%)
  • Series E (4%)
  • Seed (3%)
  • Debt Financing (1%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Therapeutics
  • Medical Device
  • Medical
  • Enterprise Software
  • Pharmaceutical
  • Life Science
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Aurora Funds frequently co-invest with?

H.I.G. Capital
North America, Florida, United States, Miami
Co-Investments: 4
Novak Biddle Venture Partners
North America, Maryland, United States, Bethesda
Co-Investments: 6
Sevin Rosen Funds
North America, Texas, United States, Dallas
Co-Investments: 5
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 5
Harbert Growth Partners
North America, Virginia, United States, Richmond
Co-Investments: 5
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 6
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 12
TT
North America, North Carolina, United States, Cary
Co-Investments: 8
Cordova Ventures
North America, Georgia, United States, Alpharetta
Co-Investments: 5
Fletcher Spaght, Inc.
North America, Massachusetts, United States, Boston
Co-Investments: 5

Which angels does The Aurora Funds often collaborate with?

Gideon Gartner
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 2

What are some of recent deals done by The Aurora Funds?

CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Debt FinancingMay 9, 2014
Amount Raised: $2,378,923
Metabolon

Morrisville, North Carolina, United States

Metabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceSoftware
Series EJan 6, 2014
Amount Raised: $14,999,980
Argos Therapeutics

Durham, North Carolina, United States

Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.

BiotechnologyHealth CareTherapeutics
Series ENov 20, 2013
Amount Raised: $17,500,000
Regado Biosciences

Durham, North Carolina, United States

Regado Biosciences develops antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.

BiotechnologyHealth CareTherapeutics
Series EDec 17, 2012
Amount Raised: $51,000,000
Cardioxyl Pharmaceuticals

Chapel Hill, North Carolina, United States

Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for the treatment of cardiovascular disease.

BiotechnologyHealth CareTherapeutics
Series BNov 13, 2012
Amount Raised: $28,000,000
Argos Therapeutics

Durham, North Carolina, United States

Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.

BiotechnologyHealth CareTherapeutics
Series DApr 24, 2012
Amount Raised: $25,000,000
Metabolon

Morrisville, North Carolina, United States

Metabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceSoftware
Series DAug 29, 2011
Amount Raised: $13,100,000
Digitalsmiths

Durham, North Carolina, United States

Digitalsmiths connects consumers to relevant video content through personalized search, recommendations, and discovery.

ContentSoftwareVideoWeb Development
Series CApr 27, 2011
Amount Raised: $12,500,000
CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Series CFeb 28, 2011
Amount Raised: $30,600,000
Cardioxyl Pharmaceuticals

Chapel Hill, North Carolina, United States

Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for the treatment of cardiovascular disease.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 2, 2010
Amount Raised: $15,000,000